Vascular endothelial growth factor is essential for corpus luteum angiogenesis
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (3) , 336-340
- https://doi.org/10.1038/nm0398-336
Abstract
The development and endocrine function of the ovarian corpus luteum (CL) are dependent on the growth of new capillary vessels. Although several molecules have been implicated as mediators of CL angiogenesis, at present there is no direct evidence for the involvement of any. Here we report the unexpected finding that treatment with truncated soluble Flt-1 receptors, which inhibit vascular endothelial growth factor (VEGF) bioac-tivity, resulted in virtually complete suppression of CL angiogenesis in a rat model of hormonally induced ovulation. This effect was associated with inhibition of CL development and progesterone release. Failure of maturation of the en-dometrium was also observed. Areas of ischemic necrosis were demonstrated in the corpora lutea (CLs) of treated animals. However, no effect on the preexisting ovarian vasculature was observed. These findings demonstrate that, in spite of the redundancy of potential mediators, VEGF is essential for CL angiogenesis. Furthermore, they have implications for the control of fertility and the treatment of ovarian disorders characterized by hypervascularity and hyperplasia.Keywords
This publication has 19 references indexed in Scilit:
- Essential Role of Growth Hormone in Ischemia-Induced Retinal NeovascularizationScience, 1997
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences, 1995
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994
- Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.Journal of Clinical Investigation, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Designing CD4 immunoadhesins for AIDS therapyNature, 1989
- Production a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum.Proceedings of the National Academy of Sciences, 1978
- The changes in the vascular pattern of the ovary of the albino rat during the estrous cycleJournal of Anatomy, 1943